Having trouble viewing this email? View in your browser.
ESCMID Logo

24 May 2016
WEEKLY NEWS

Dear colleagues,

Gunnar Kahlmeter explains the role of EUCAST’s antimicrobial susceptibility breakpoints for the fight against resistance in an article in Pharmtech. Other publications of interest are the UK’s review on Antimicrobial Resistance where the final report outlines the issues and recommendations. And the European Medicines Agency also published its 2015 annual report, which focuses on the agency’s core tasks: evaluation of medicines, support to R&D of new treatments and monitoring of benefits and risks of medicines.

Best regards, your ESCMID communications editors

 

Diagnostic test to win EU Horizon Prize for better use of antibiotics

The European Commission will award EUR 1 million for the development of a rapid diagnostics test that will allow healthcare providers to distinguish at the point of care between patients with upper respiratory tract infections that require antibiotics and those that can be treated safely without antibiotics. The challenge is to develop a test that is cheap, rapid and easy-to-use for healthcare providers and non- or minimally invasive for patients. By stopping many patients from taking antibiotics needlessly, it will prevent the side effects of such unnecessary treatment, eliminate the cost of prescribing the antibiotics and, most importantly, decrease the development of resistant bacteria. Contestants can submit entries until 17 August 2016. The rules of contest are available online. For information on this call and other EU funding, check out our website.

› Read more
 

CMI highlight: comparison of fluconazole vs echinocandins in candidemia

Researchers in Spain conducted one of the largest studies comparing the clinical efficacy of fluconazole and echinocandins in the treatment of candidemia. They conclude that empirical or targeted treatment with fluconazole was not associated with increased 30-day mortality among adults. The researchers conclude that echinocandins should not necessarily be preferred for more severely ill cases. The article can be found at CMI under this link

› Read more
 

Check out our gallery for ECCMID 2016

The ECCMID 2016 gallery offers some impressions from our annual congress in Amsterdam. 

› Read more
ESCMID Executive Office
P.O. Box 214
4010 Basel
Switzerland
Phone +41 61 5080 173
info@escmid.org
www.escmid.org
Follow ESCMID
Visit us on LinkedIn Visit us on YouTube
 
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.